Clinical Trials
7 trialsNCT05891171 2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1 Active not recruiting
NCT06727565 2026-03-02
VELOCITY-HNSCC
Gilead Sciences
Phase 2 Active not recruiting
NCT04854499 2025-11-19
ELEVATE HNSCC
Gilead Sciences
Phase 2 Terminated
NCT06790706 2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2 Recruiting
NCT03629756 2024-05-24
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed
NCT04892875 2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1 Withdrawn
NCT06107114 2023-11-22
CZCNRHNSCC
Sun Yat-sen University
Phase 2 Unknown